Moderna launches new charitable foundation

Initial grants of approximately $5 million awarded to local and global nonprofits that support groups and causes disproportionately affected by covid-19 cambridge, ma / accesswire / april 4, 2022 / moderna, inc. (nasdaq:mrna), a biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines, today announced the launch of the moderna charitable foundation to promote public health, access to quality healthcare and educational opportunities, particularly in underserved populations. "we founded moderna based upon the idea that we can make a transformative positive impact through our medicines, and the work of the moderna charitable foundation will accelerate our efforts to improve health globally, particularly for those with inadequate access to health and medicine," said noubar afeyan, co-founder and chairman of moderna.
MRNA Ratings Summary
MRNA Quant Ranking